Introduction {#sec1-1}
============

Senescence is an obstacle to cell proliferation. It was first introduced by Hayflick and his colleagues about 50 years ago ([@ref1]). Recent studies have shown that this process plays an important role in many aspects of biological events such as aging, tissue repair and tumor suppression ([@ref2]). P16/pRb and p53/p21 are two main pathways mainly involved in senescence but ongoing studies should be performed to completely elucidate its mechanisms ([@ref3]).

It has been forty years since senescence was first defined as a cellular proliferation barrier. Nowadays, it has become clear that senescence is more than a simple process, and involves many mechanisms ([@ref2], [@ref4]). One kind of senescence which emerges in mild stress conditions with no effect on telomere length is stress-induced premature senescence (SIPS). There are several factors which induce SIPS *in vitro* including trivial wrecking agent, scarcity of nutrient or contaminated environments with reactive oxygen species. Among these factors, oxidative stress plays the most important role in inducing SIPS ([@ref5]).

Lipocalin 2 (Lcn2) is one of the strategic molecules that are expressed under oxidative stress conditions. Lcn2 which is also called neutrophil gelatinase-associated lipocalin (NGAL) belongs to a small family but with important duties. Lcn2 is induced under various pathophysiological conditions such as cancer ([@ref6], [@ref7]), inflammation ([@ref8], [@ref9]), cardiovascular disease ([@ref10], [@ref11]), intoxication ([@ref12]), infection ([@ref13]), oxidative stress ([@ref14]) and considerably following renal injury ([@ref9], [@ref15]). As a matter of fact, the expression of Lcn2 rises to about 1000-fold in human and rodents in response to renal tubular injury, and its fast appearance in urine and serum makes it a useful early biomarker of renal failure ([@ref16]).

Nevertheless, the precise role of Lcn2 has still remained unknown ([@ref17]). Interestingly, stimulators of Lcn2 expression are similar to those implicated in cellular senescence.

In our previous study, we investigated the effect of Lcn2 on the senescence of mesenchymal stem cells that have finite proliferation ([@ref18]), but here we investigated the influence of Lcn2 on human embryonic kidney (HEK) cells which can undergo numerous proliferations. This study was performed to investigate the relationship between Lcn2 expression and senescence in the kidney-derived cell line. Since H~2~O~2~ is a well-known factor to induce senescence, therefore we over-expressed Lcn2 in HEK-293 cells and then studied the incidence of senescence in this cell line under sub-lethal doses of H~2~O~2~.

Materials and Methods {#sec1-2}
=====================

Cell Culture {#sec2-1}
------------

Human hepatoma (HepG2) and human embryonic kidney 293 (HEK-293) were obtained from National Cell Bank (NCBI) of Pasteur Institute of Iran. These cell lines were grown in roswell park m institute-1640 (RPMI-1640) medium (Gibco-BRL, Germany) with 10% fetal bovine serum (FBS) (Gibco-BRL, Germany).

Isolation and cloning of Lcn2 cDNA {#sec2-2}
----------------------------------

HepG2 cells were cultured in 25 cm^2^ flasks stuffed with RPMI medium with 10%FBS. Total mRNA was extracted from the cells using RNeasy spin column kit (Qiagen, Germany), and subjected to cDNA synthesis using cDNA synthesis kit (Bioneer, Korea). Specific primer set, forward (5′-ACG AAT TCA CCA TGG TGC CCC TAG GTC TCC TGT GGC TG-3′) and reverse (5′-TAG CGG CCG CTC AGC CGT CGA TAC ACT GGT C-3′), and platinum Taq DNA polymerase (Invitrogen. USA) were used to amplify total length of human Lcn2. The amplified Lcn2 cDNA was cloned into mammalian expression vector pcDNA3.1 as described previously ([@ref19]).

Plasmid transfection {#sec2-3}
--------------------

The HEK-293 cells were transfected with 2μg of the pcDNA3.1 and pcDNA3.1-Lcn2 plasmids using FugenHD (Invitrogen, USA) according to the manufacturer's protocol. Stable clones expressing recombinant lcn2 were established in the presence of 500 µg/ml of G418 (Sigma, USA). Then, the expression of Lcn2 mRNA and protein was evaluated by RT-PCR and ELISA.

Reverse transcriptase polymerase chain reaction {#sec2-4}
-----------------------------------------------

To evaluate the expression of Lcn2 in transfected cells (HEK293-Lcn2), reverse transcriptase polymerase chain reaction (RT-PCR) was performed 72 hrs after transfection. Total mRNA was extracted from the cells as previously mentioned and reverse transcribed into cDNA using cDNA Synthesis kit according to the manufacturer's suggested protocol. The expression of Lcn2 was measured with a primer pair, forward: 5'-TCACCTCCGTCCTGTTTAGG-3' and reverse: 5'-CGAAGTCAGCTCCTTGGTTC-3' that could amplify a fragment of the human Lcn2 mRNA with the length of 240 bp. The expression of β-actin, a housekeepping gene, was also measured as control. Sequence of β-actin primers were as follows: Forward: 5′-TTCTACAATGAGCTGCGTGTGG- 3′ and Reverse: 5′-GTGTTGAAGGTCTCAAACATGAT- 3′. PCR was performed with thermal cycling conditions including the primary denaturation step at 94 °C for 4 min followed by 35 cycles of denaturation at 94 °C for 30 sec, annealing at 59 °C for 30 sec, extension at 72 °C for 20 sec, and final extension at 72 °C for 5 min. Ultimately, electrophoresis on 2% agarose gel was applied to analyze PCR products.

Enzyme linked immune-sorbent assay {#sec2-5}
----------------------------------

Enzyme-linked immune sorbent assay (ELISA) was performed to evaluate the expression of Lcn2 protein. Human Lipocalin-2/NGAL immunoassay kit (R&D systems,USA) was used to determine the level of Lcn2 protein secreted into medium. 72 hrs after transfection, the medium was harvested. The samples were diluted (1:20) with a diluent solution, RD1-52 reagent, according to the manufacturer's protocol. Next, 100 µl of RD1-52 was added to each well and 50 µl of diluted samples were added and the plates were incubated at 4 °C for 2 hr. After rinsing the wells with washing buffer, 200 µl HRP-conjugated anti-Lcn2 antibody was added to each well. Wells were covered and incubated at 4°C for 2 hr, and they were again rinsed with washing buffer. Next, 200 µl of the substrate solution was added to each well and the well plate was incubated at room temperature for 30 min in the dark. Finally, 50 µl of stop solution was added to each well, and the OD values were only measured at 450 nm using microplate reader.

H~2~O~2~ treatment {#sec2-6}
------------------

To treat different cell groups with sub-lethal dose of H~2~O~2~, the HEK-293-V (transfected with empty pcDNA3.1 plasmid) and HEK293-Lcn2 (transfected with pcDNA3.1-Lcn2) cells were cultured in RPMI 1640 containing 10% FBS at 37 °C and 5% CO~2~ in humidified incubator along with control group. H~2~O~2~ with final concentration of 80 µM was added to the culture medium for different time duration (12-18 hr) to identify the optimized exposure time. Then, the medium was changed to recover the cells.

Cell proliferation assay {#sec2-7}
------------------------

Different HEK-293 groups including HEK-293-V, HEK293-Lcn2, H~2~O~2~-treated HEK-293-V (HEK-293-V/H~2~O~2~), and H~2~O~2~-treated HEK293-Lcn2 (HEK-293-Lcn2/H~2~O~2~) were seeded in 96-well plate at the density of 3×103 cells/well. H~2~O~2~ treatment was performed as described above after determining the optimized exposure time (80 µM of H~2~O~2~ for 18 hr). Then, cells were cultured in CO~2~ incubator at 37 °C. The medium was changed three times a week. After one week, cells were subjected to cell proliferation assay using water soluble tetrazolium salts-1 (WST-1) kit (Roche, Germany) according to manufacturer's protocol. Next, the absorbance was measured using ELx800 Absorbance Microplate Reader at 450 nm. In addition, 1×10^4^ of these mentioned cells were seeded in a 6-well plate both with and without H~2~O~2~ treatment and incubated at 37 °C with 5% CO~2~. Afterwards, the cells were trypsinized and detached every 3 days and their viability was measured with 0.4% trypan blue (Sigma, USA).

Senescence-associated β-Galactosidase Staining {#sec2-8}
----------------------------------------------

The senescent cells were detected with senescence β-galactosidase staining kit (Cell Signaling, Beverly, MA, USA) according to manufacturer's protocol. The growth media was removed and the cells were once rinsed with PBS. Next, a fixative solution containing 2% formaldehyde and 0.2% glutaraldehyde was added to the cells. Then, again the cells were rinsed with PBS two times and incubated with a staining solution containing 5-bromo-4-chloro-3-indolyl-D-galactopyranoside, citric acid/sodium phosphate (pH 6.0), 1.5 M NaCl, 20 mM MgCl~2~, potassium ferrocyanide and potassium ferricyanide. After 11 to 14 hr, light microscopy was applied to identify the senescent cells which can be visualized as blue cells. Thirty fields were randomly selected to calculate the percentage of SA-β-gal cells.

Real-Time RT-PCR Analysis {#sec2-9}
-------------------------

The expression of some genes that are attributed to be involved in senescence ([@ref20]) were studied using real time RT-PCR analysis. The total RNA of H~2~O~2~-treated and non-treated HEK293-Lcn2 was extracted and the cDNA was generated as described above. Real time RT-PCR was performed to amplify the desired fragments using SYBR green PCR master mix (Takara, Japan) and specific primer sets including p16INK4a forward: 5'-GACATCCCCGATTGAAAGAA3' and reverse: 5'TTTACGGTAGTGGGGGAAGG3'; P27KIP1 forward: 5'-TACAGACCCCCGCGGCCC-3' and reverse: 5'-TCCGCTAACCCCGTCTGGCT-3'; p53 forward: 5'-GGCCCACTTCACCGTACTAA-3' and reverse: 5'-GTGGTTTCAAGGCCAGATGT -3'; as well as Lcn2 primers (primer sequence was described above). These primers were designed and blasted using NCBI database. PCR was performed with Rotor-gene RG-3000 (Corbett, Germany) and the corresponding PCR conditions. In each reaction 2 µl of cDNA was used in a mixture containing 25 μl of SYBR green PCR master mix (Takara, Japan) and 10 pmol of each gene-specific primer. The amplification program was as follows: 1 min of preincubation at 95 °C followed by 40 cycles of 15 sec at 94 °C, 30s at optimized annealing temperature of each primer pair, and 30 sec at 72 °C and then a step of 10 sec at 82 °C followed by melting curve analysis. Data analysis was assessed using the Rotor Gene software. Ct values were calculated and relative expression of the target genes was determined after normalization against β-actin expression as an endogenous standard.

Gimsa staining {#sec2-10}
--------------

Gimsa stain was employed to assess the size of the enlarged senescent cells. Cells were seeded on slides and incubated overnight. Then the culture media was removed and the cells were rinsed with PBS. The process was followed by soaking the slides in absolute methanol for 10 min; then, the slides were rinsed with water and soaked in 10% gimsa stain for 15 min, and finally, the slides were rinsed again with water and the cells were detected in violet under light microscopy.

Statistical analysis {#sec2-11}
--------------------

Statistical analysis was performed using analysis of variance (ANOVA) and Student's t-test. In all of the tests, the significance was considered as *P*\<0.05.

Result {#sec1-3}
======

Over-expression of Lcn2 in HEK-293 cells {#sec2-12}
----------------------------------------

HEK-293 cells were transfected with pcDNA3.1-Lcn2 in order to over-express Lcn2. 72 hr later, Lcn2 expression in transfected cells was confirmed by RT-PCR (data not shown). Being assayed with real time RT-PCR ([Figure 1](#F1){ref-type="fig"}), the expression level of Lcn2 in HEK-lcn2 cells was estimated higher than that of HEK-V cells (which were transfected with empty pcDNA3.1 vector). ELISA confirmed these results and demonstrated ectopic over-expression of Lcn2 in HEK-lcn2 cells ([Table 1](#T1){ref-type="table"}).

![Assessment of Lcn2 expression at transcriptional level in HEK-293 by real-time RT-PCR. 72 hrs after transfection, the expression of Lcn2 in transfected cells was evaluated. The expression of Lcn2 mRNAs was significantly up-regulated in HEK293 transfected with Lcn2 compared with untransfected cells](IJBMS-18-459-g001){#F1}

###### 

ELISA for Lcn2 immunoassay. The Lcn2 concentration was calculated using standard curve in proportion to dilution ratio

  Standards & Samples   Absorbance (450nm)   Lcn2 concentration (ng/ml)
  --------------------- -------------------- ----------------------------
  St 1 A                1.75                 10
  St 2 A                0.909                5
  St 3 A                0.523                2.5
  St 4 A                0.285                1.25
  HEK-VB                0.098                0.5\*
  HEK-Lcn2B             1.65                 170\*

A: Standard concentrations of human Lcn2 provided in the kit, B: the samples, \* to calculate the final concentration of Lcn2, the values were multiply by dilution factors (20 times)

Lcn2 expression is induced in HEK-293 cell lines by Oxidative stress {#sec2-13}
--------------------------------------------------------------------

After several examinations, treatment with 80 µM of H~2~O~2~ for 18 hr was determined as optimized protocol to induce oxidative stress. Then, Lcn2 expression was evaluated both under normal and oxidative stress conditions using real time RT-PCR. Being exposed to sub-lethal doses of H~2~O~2~, HEK-293 significantly increased the lcn2 expression, while in normal condition; the cell line was able to express far lower level of Lcn2. This fact was disclosed by RT-PCR (data not shown) and then certified by real time PCR analysis ([Figure 2](#F2){ref-type="fig"}).

![Evaluation of Lcn2 expression in HEK-293 with real-time RT-PCR following H~2~O~2~ treatment. The ratio of Lcn2 to β-actin expression was assessed both before and after treatment with H~2~O~2~. The expression level of Lcn2 increased significantly following HEK-293 treatment with H~2~O~2~](IJBMS-18-459-g002){#F2}

Lcn2 Over-expression differently affects the proliferation of the HEK-293 cells in both normal and oxidative stress conditions {#sec2-14}
------------------------------------------------------------------------------------------------------------------------------

WST-1 was performed to determine the proliferation rate of different cell groups (H~2~O~2~-treated and non-treated). Colony assay was also carried out and the number of colonies was enumerated. The findings disclosed that when Lcn2 was over-expressed in the cells, the number of colonies increased under normal condition. In other words, HEK-293-Lcn2 colonies were more than those of HEK-293-V. However, when treated with H~2~O~2~, Lcn2 not only did not increase cell proliferation in HEK-293 cells, but it also slightly decreased their proliferation rate ([Figure3](#F3){ref-type="fig"}). After H2O2 treatment, the number of HEK-Lcn2 colonies inside the plate was less than that of HEK-V's ([Figure 3](#F3){ref-type="fig"}).

![The number of colonies of HEK-V and HEK-Lcn2 either with or without H~2~O~2~ treatment. The number of colonies was counted using gimsa staining. Under normal condition (without any H~2~O~2~ treatment) the number of HEK-Lcn2 colonies was more than HEK-V. However, after H~2~O~2~ treatment, the number of colonies in HEK-Lcn2 decreased compared with HEK-V (data represents mean±SD; number of replicates=3, \**P*\<0.05, \*\*\**P*\<0.001)](IJBMS-18-459-g003){#F3}

Lcn2 affects the incidence of senescence in HEK 293 under oxidative stress condition {#sec2-15}
------------------------------------------------------------------------------------

To investigate the Lcn2 over-expression effects on HEK-293 senescence both under normal and oxidative stress conditions, the cells were subjected to β-gal and gimsa staining. Gimsa staining results indicated the increasing number of enlarged HEK 293 cells, as a senescence sign, after H~2~O~2~ treatment ([Figure4A.I](#F4){ref-type="fig"}) compared with normal conditin([Figure 4A.II](#F4){ref-type="fig"}). Next, β-gal staining was exerted to indicate blue cells as senescent cells. As shown in [Figure4A.III](#F4){ref-type="fig"}, positive β-gal staining was observed in H~2~O~2~-treated cells while there were no blue senescent cells under normal condition with no H~2~O~2~ treatment ([Figure4A.IV](#F4){ref-type="fig"}). Quantification of β-gal staining results showed the number of senescent cells in HEK-V and HEK-Lcn2 both under normal and oxidative conditions. In normal condition, the number of senescent HEK-V was more than that of HEK-Lcn2, but when the cells were treated with H~2~O~2~, the number of senescent HEK-Lcn2 cells increased significantly ([Figure 4B](#F4){ref-type="fig"}). As a result, Lcn2 increases the senescence of HEK-293 cells under oxidative stress condition.

![Detection of senescence before and after treatment with sub-lethal dose of H~2~O~2~ using gimsa and β-gal staining. A. Gimsa staining results indicated H~2~O~2~-induced cell enlargement through senescence in HEK-Lcn2 cells (I) compared with non-treated ones (II). Morover, β-gal staining confirmed the presence of blue cells after H~2~O~2~ treatment (III) while these blue cells were not seen (or seen rarely) in HEK-Lcn2 group (IV) (Scale bar: 25 µm) B. Quantitative assay of β-Gal positive cells. The sub-lethal dose of H~2~O~2~ prompted senescent phenotype in HEK-Lcn2 and senescence increased in HEK-Lcn2/H~2~O~2~ cells. (Data represents mean± SD; number of replicate=3, \**P*\<0.01, \*\*\**P*\<0.001)](IJBMS-18-459-g004){#F4}

Over-expression of Lcn2 up-regulates the senescence-related genes in HEK 293 cell line {#sec2-16}
--------------------------------------------------------------------------------------

The expression of p16, p27 and p53 genes, as senescence-related genes, were evaluated with real time RT-PCR technique. Relative expression of the target genes was determined after normalization against β-actin expression as a housekeeping gene. Following H~2~O~2~ treatment, Lcn2 up-regulated the expression of p16, p27 and p53 ([Figure 5](#F5){ref-type="fig"}). Overall, in consistent with previous results, after exposing the HEK-293-Lcn2 cells to H~2~O~2~, Lcn2 increased the rate of senescence in these cells. Generally, in a normal condition, HEK-Lcn2 cells express the senescence genes minimally, while they highly express these genes during stressful conditions.

![Real time RT-PCR analyses for p16, p27, p53 genes expressed in HEK-293/HEK-Lcn2 either with or without exposure to oxidative stress. According to these findings, HEK-293 expressed higher level of senescence-related genes compared to HEK-Lcn2 under normal condition. Besides, the expression of these genes were up-regulated in HEK-293-Lcn2/H~2~O~2~ under oxidative stress condition](IJBMS-18-459-g005){#F5}

Discussion {#sec1-4}
==========

Oxidative stress is involved in inducing stress-induced premature senescence (SIPS), but its mechanism is not clearly defined. We designed an experiment for a model of cells with infinite proliferation i.e. the immortal HEK-293 cell line to study the effects of both Lcn2 expression and oxidative stress on senescence which is considered as an obstacle to cell proliferation.

This cell line was selected in the current study as an *in vitro* model to assess the over-expression of Lcn2 on the incidence of senescence. Since Lcn2 is dramatically induced following kidney injury, and the corresponding oxidative stress condition ([@ref15]), we somewhat used kidney cells to understand the role of Lcn2 induction under oxidative stress. Therefore, we examined whether, in oxidative stress situations, Lcn2 can protect cells against stressors and decrease senescence. Unexpectedly, we observed that these engineered cells respond differently to either normal or oxidative stress conditions. Our results indicated that the different responses can be attributed to a cellular phenomenon called senescence. H~2~O~2~ considerably induced Lcn2 expression in HEK 293 cell line, while Lcn2 was slightly up-regulated when naïve hB-MSCs were exposed to sub-lethal doses of H~2~O~2~ ([@ref18]). This could be due to the presence of huge antioxidant depository in MSCs ([@ref21], [@ref22]). Which eliminates the necessity of Lcn2 induction and its protective effects.

Similar to hB-MSCs, the over-expression of Lcn2 in HEK-293 enhances cell proliferation. Interestingly and unexpectedly, under oxidative stress condition, Lcn2 increases senescence in HEK-293 cells, while it decreases this biological process in hB-MSCs ([@ref18]). This discrepancy in the role of Lcn2 in HEK-293 and hB-MSCs could be due to the evolutionary nature of these cells. The role of Lcn2 in hB-MSCs under oxidative stress condition could be due to the fact that these are virgin and naïve cells and should be kept away from early aging to fulfill its regenerative potentials. Therefore, it seems that senescence inhibition of hB-MSCs under harmful conditions such as oxidative stress is in favor of their regenerative potentials. The role of Lcn2 in HEK-293 cells under oxidative stress condition could be due to the fact that these are cell lines with infinite proliferation rate and the story is different, here. It seems that under such a condition Lcn2 by increasing the rate of senescence plays a suppressing role for HEK-293 cells in order to prevent further damages. In other words, senescence might similarly act as tumor suppressor gene.

Little is known about the relationship of Lcn2 and senescence in normal cells and tissues. However, we know that after kidney injury, the expression of Lcn2 is induced immediately and dramatically. This dramatic up-regulation of Lcn2 is a compensatory reaction to re-establish the hemostasis. Interestingly, Mishra *et al* showed that administration of recombinant Lcn2 ameliorate kidney injury following AKI in mice model ([@ref15]). However, the precise role of Lcn2 with regard to senescence especially *in vivo* warrants further study.

Conclusion {#sec1-5}
==========

In this study, we reported that when HEK-293 cells are exposed to the challenging condition of oxidative stress, Lcn2 or NGAL increases cellular senescence. In other words, our results suggest that Lcn2 regulates cell survival through senescence under harmful conditions. However further and complementary studies are required to clarify the precise role of Lcn2 in senescence.

We thanks Dr Mohammad Ali Jalili and Mahshid Mohammadipour for their technical helps (IBTO, Tehran, Iran)
